Atrial fibrillation (AF) is a type of cardiac arrhythmia which is caused by irregular electrical activities in the atria. It may occur with no symptoms but most common ones associated with it are fainting, palpitations, congestive failure of the heart or chest pain.
Factors such as aging of population and sedentary life style resulting in rapidly increasing prevalence of cardiac diseases worldwide are driving the growth of the global atrial fibrillation diagnostics market. On the other hand, high cost involved in diagnosis of atrial fibrillation on the grounds of high equipment costs and scarce availability of diagnostic facilities is restraining the growth of atrial fibrillation diagnostics market. As atrial fibrillation diagnostic tools are costly, reprocessed diagnostic catheters market shows growth potential.
North America is dominating the global atrial fibrillation diagnostics market and is followed by Europe. Asia-Pacific is a lucrative market for global atrial fibrillation diagnostics due to increasing healthcare spending and rapidly increasing awareness about the diseases.
In 2018, the global Atrial Fibrillation (AF) Diagnostics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Atrial Fibrillation (AF) Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Atrial Fibrillation (AF) Diagnostics development in United States, Europe and China.
The key players covered in this study
Dickinson & Company
Boston Scientific Corp
St. Jude Medical
Market segment by Type, the product can be split into
Transesophageal Echocardiography (TEE)
Tilt Table Tests
Electrical Activity Testing
Market segment by Application, split into
Heart Specialty Care Enterprises
Market segment by Regions/Countries, this report covers
Central & South America
The study objectives of this report are:
To analyze global Atrial Fibrillation (AF) Diagnostics status, future forecast, growth opportunity, key market and key players.
To present the Atrial Fibrillation (AF) Diagnostics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Atrial Fibrillation (AF) Diagnostics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.